Dr. Michele Tagliati is a clinician and clinical researcher, investigating advanced therapeutics of Parkinson’s disease, dystonia and other movement disorders. He was among the pioneers developing the use of deep brain stimulation (DBS) for movement disorders in the United States. Dr. Tagliati attended medical school and neurology residency in Rome, Italy before moving to New York in 1993. He completed a second residency in neurology at the Mount Sinai School of Medicine, during which time he was Chief resident. Following residency, he completed a fellowship in Movement Disorders at Beth Israel Medical Center and afterward joined the Department of Neurology as an attending and faculty at Albert Einstein College of Medicine. In 2004, Dr. Tagliati moved back to Mount Sinai, where he was an Associate Professor of Neurology and Division Chief of Movement Disorders. In 2010, accepted the position of Vice Chairman of Neurology and Director of Movement Disorders at Cedars Sinai Medical Center in Los Angeles. In 2015, he was awarded the Caron and Steven D. Broidy Endowed Chair for Movement Disorders. Dr. Tagliati has received research grants and support in excess of 4 million dollars from various agencies and foundations and has been a Principal Investigator in over 45 clinical trials exploring new medical and surgical therapies for Parkinson’s disease and dystonia. Currently, his research is directed at the study of non-motor and pre-motor symptoms of Parkinson’s disease, including investigator-initiated trials of liraglutide in Parkinson’s disease and adrenergic blockers in subjects at high risk of developing PD. Dr. Tagliati holds 2 international patents on subjects related to Parkinson prevention and DBS optimization. Dr. Tagliati is a diplomate of the American Board of Psychiatry and Neurology. He has published over 100 peer-reviewed articles and 30 book chapters and is co-author of the patient reference book Parkinson’s Disease for Dummies. Dr. Tagliati has lectured at conferences and academic institutions around the world and is one of the premier educators of DBS management, having directed – among others - the DBS programming course at the annual meeting of the American Academy of Neurology. An active member of the American Academy of Neurology and the Movement Disorders Society, Dr. Tagliati also serves in the Editorial Board of the Journal of Parkinson’s Disease and Nature Parkinson’s disease.